Cell-free synthesis companies develop systems that produce proteins and other biological molecules without using intact living cells. These platforms enable rapid expression, prototyping and manufacturing under controlled in vitro conditions.
This category includes companies working on:
Browse 5 UK cell-free synthesis companies below.
Enzymatic synthetic DNA manufacture for gene therapy and molecular biology
NunaBio is a specialist DNA synthesis company developing a cell-free enzymatic platform for scalable production of synthetic DNA, including long oligonucleotides, whole genes and…
Benchtop platform for rapid cell-free protein expression and screening
Nuclera is a Cambridge-based biotechnology company developing benchtop systems for rapid protein expression and screening. Its discovery platform integrates cell-free protein…
AI-guided plant biosynthesis platform for novel therapeutic compounds
HotHouse Therapeutics is a drug discovery platform company that engineers plants as sustainable biofactories for pharmaceutical compound production. Using AI to design and…
Cell-free enzymatic synthesis platform for biotherapeutic discovery
Newcleic is a biotech developing cell-free, enzymatic synthesis methods and systems to accelerate biotherapeutic discovery and manufacture. The platform uses cell-extracted or…
Carbon capture and biomanufacturing using engineered cyanobacteria
CyanoCapture is a company developing a biomanufacturing platform that uses genetically engineered cyanobacteria to sequester carbon dioxide and convert it into high-value products…